Metraipolis › archive › dc_76dd87d81580
Kidney tumors associated with germline mutations of FH and SDHB show a CpG island methylator phenotype (CIMP) — Europe PMC PMID:36455002
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/36455002
- DOI
- 10.1371/journal.pone.0278108
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-10T02:58:11.819Z
- SHA-256 of the archived text
50fe489040d561853a20d8ed9f1853aa6882c8d0c62f6e48746e1cdd5f1547b3- Stable URL of this page
https://metraipolis.com/documento/dc_76dd87d81580
How to cite
Kidney tumors associated with germline mutations of FH and SDHB show a CpG island methylator phenotype (CIMP) — Europe PMC PMID:36455002 — Europe PMC (en), https://europepmc.org/article/MED/36455002 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_76dd87d81580 (Metraipolis archive dc_76dd87d81580, sha256 50fe489040d561853a20d8ed9f1853aa6882c8d0c62f6e48746e1cdd5f1547b3)
BibTeX
@misc{dc76dd87d81580,
title = {Kidney tumors associated with germline mutations of FH and SDHB show a CpG island methylator phenotype (CIMP) — Europe PMC PMID:36455002},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/36455002},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_76dd87d81580; sha256 50fe489040d561853a20d8ed9f1853aa6882c8d0c62f6e48746e1cdd5f1547b3},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/36455002. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Germline mutations within the Krebs cycle enzyme genes fumarate hydratase (FH) or succinate dehydrogenase (SDHB, SDHC, SDHD) are associated with an increased risk of aggressive and early metastasizing variants of renal cell carcinoma (RCC). These RCCs express significantly increased levels of intracellular fumarate or succinate that inhibit 2-oxoglutarate-dependent dioxygenases, such as the TET enzymes that regulate DNA methylation. This study evaluated the genome-wide methylation profiles of 34 RCCs from patients with RCC susceptibility syndromes and 11 associated normal samples using the Illumina HumanMethylation450 BeadChip. All the HLRCC (FH mutated) and SDHB-RCC (SDHB mutated) tumors demonstrated a distinct CpG island methylator phenotype (CIMP). HLRCC tumors demonstrated an extensive and relatively uniform level of hypermethylation that showed some correlation with tumor size. SDHB-RCC demonstrated a lesser and more varied pattern of hypermethylation that overlapped in part with the HLRCC hypermethylation. Combined methylation and mRNA expression analysis of the HLRCC tumors demonstrated hypermethylation and transcription downregulation of genes associated with the HIF pathway, HIF3A and CITED4, the WNT pathway, SFRP1, and epithelial-to-mesenchymal transition and MYC expression, OVOL1. These observations were confirmed in the TCGA CIMP-RCC tumors. A selected panel of probes could identify the CIMP tumors and differentiate between HLRCC and SDHB-RCC tumors. This panel accurately detected all CIMP-RCC tumors within the TCGA RCC cohort, identifying them as HLRCC -like, and could potentially be used to create a liquid biopsy-based screening tool. The CIMP signature in these aggressive tumors could provide both a useful biomarker for diagnosis and a target for novel therapies. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PloS one, 2022 (prima pubblicazione 2022-12-01). Identificativi: PMID 36455002 · PMCID PMC9714951 · DOI 10.1371/journal.pone.0278108. Descrittori MeSH principali: Carcinoma, Renal Cell; Kidney Neoplasms. Pagina: https://europepmc.org/article/MED/36455002 — https://doi.org/10.1371/journal.pone.0278108. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-10-10T02:37:36.864Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.